These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16547504)
1. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Burnworth B; Popp S; Stark HJ; Steinkraus V; Bröcker EB; Hartschuh W; Birek C; Boukamp P Oncogene; 2006 Jul; 25(32):4399-412. PubMed ID: 16547504 [TBL] [Abstract][Full Text] [Related]
2. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740 [TBL] [Abstract][Full Text] [Related]
3. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer. Utikal J; Udart M; Leiter U; Kaskel P; Peter RU; Krähn G Cancer Lett; 2005 Mar; 219(2):197-204. PubMed ID: 15723720 [TBL] [Abstract][Full Text] [Related]
4. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Boukamp P; Popp S; Bleuel K; Tomakidi E; Bürkle A; Fusenig NE Oncogene; 1999 Oct; 18(41):5638-45. PubMed ID: 10523843 [TBL] [Abstract][Full Text] [Related]
6. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens. Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441 [TBL] [Abstract][Full Text] [Related]
7. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551 [TBL] [Abstract][Full Text] [Related]
8. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Sauter ER; Nesbit M; Litwin S; Klein-Szanto AJ; Cheffetz S; Herlyn M Cancer Res; 1999 Oct; 59(19):4876-81. PubMed ID: 10519399 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Lung JC; Chu JS; Yu JC; Yue CT; Lo YL; Shen CY; Wu CW Genes Chromosomes Cancer; 2002 Jul; 34(3):276-84. PubMed ID: 12007188 [TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340 [TBL] [Abstract][Full Text] [Related]
12. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile. Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770 [TBL] [Abstract][Full Text] [Related]
13. Expression of class II beta-tubulin in non-melanoma cutaneous tumors. Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer. Skomedal H; Forus A; Holm R Anticancer Res; 2003; 23(5A):3929-35. PubMed ID: 14666699 [TBL] [Abstract][Full Text] [Related]
15. Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures. Gioeli D; Conway K; Weissman BE Cancer Res; 1997 Mar; 57(6):1157-65. PubMed ID: 9067287 [TBL] [Abstract][Full Text] [Related]
16. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma. Utikal J; Udart M; Leiter U; Peter RU; Krähn G Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813 [TBL] [Abstract][Full Text] [Related]
17. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350 [TBL] [Abstract][Full Text] [Related]
18. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Hui AB; Or YY; Takano H; Tsang RK; To KF; Guan XY; Sham JS; Hung KW; Lam CN; van Hasselt CA; Kuo WL; Gray JW; Huang DP; Lo KW Cancer Res; 2005 Sep; 65(18):8125-33. PubMed ID: 16166286 [TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 negatively regulates the expression of differentiation genes in HT-29 M6 mucus-secreting colon cancer cells. Mayo C; Mayol X Cancer Lett; 2009 Aug; 281(2):183-7. PubMed ID: 19303206 [TBL] [Abstract][Full Text] [Related]
20. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis. Yamamoto M; Tamakawa S; Yoshie M; Yaginuma Y; Ogawa K Mol Carcinog; 2006 Dec; 45(12):901-13. PubMed ID: 17013836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]